Ovid Therapeutics
Financial ratios & Valuation

Forward Multiples (2025 – 2028)

2025202620272028
Price/Earnings ratio
-1.72-1.54-1.64-3.18
Price/Sales ratio
1.689.181.290.96
Earnings per Share (EPS)
$-0.54$-0.60$-0.56$-0.29

Historical Multiples (2014 – 2023)

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 TTM Median
Valuation Ratios
Price/Earnings ratio
-130.28-18.24-10.71-2.94-1.14-2.74-1.671.76-2.54-4.34-3.56-2.74
Price/Sales ratio
N/AN/AN/AN/AN/AN/A10.701.0387.16580.22128.40N/A
Price/Book Value ratio
12.283.524.872.281.532.323.091.200.992.581.452.32
Price/Cash Flow ratio
-222.84-43.77-13.48-6.06-1.30-3.18-2.611.82-2.37-4.96-3.49-3.18
Price/Free Cash Flow ratio
-221.33-43.32-13.34-6.05-1.29-3.17-2.591.82-2.31-4.94-3.40-3.17
Price/Earnings Growth ratio
N/A-0.02-0.15-0.010.030.090.19-0.000.01-3.160.020.09
Dividend Yield
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
N/AN/AN/AN/AN/AN/A100%100%8.06%100%N/AN/A
Operating Profit Margin
N/AN/AN/AN/AN/AN/A-645.39%59.60%-3696.43%-15134.59%-3696.40%N/A
Pretax Profit Margin
N/AN/AN/AN/AN/AN/A-642.26%59.58%-3604.66%-13362.17%-3601.33%N/A
Net Profit Margin
N/AN/AN/AN/AN/AN/A-639.82%58.94%-3420.95%-13362.17%-3604.66%N/A
Effective Tax Rate
N/AN/A0.00%0.12%-1.83%1.99%0.37%1.07%5.09%N/A-0.09%-1.83%
Return on Assets
-9.19%-18.69%-42.26%-72.44%-109.08%-73.29%-106.32%63.13%-33.10%-36.33%-34.88%-109.08%
Return On Equity
-9.43%-19.33%-45.47%-77.67%-133.95%-84.62%-185.02%68.33%-38.86%-59.61%-36.63%-133.95%
Return on Capital Employed
-9.43%-19.37%-45.71%-77.91%-136.40%-87.34%-151.18%69.10%-37.46%-44.72%-37.46%-136.40%
Liquidity Ratios
Current Ratio
N/AN/AN/A14.715.007.573.39N/AN/AN/A18.795.00
Quick Ratio
40.4130.4313.9714.715.007.573.3912.8718.799.5518.455.00
Cash ratio
40.4030.2813.9114.474.123.973.2612.6918.452.356.414.12
Days of Sales Outstanding
N/AN/AN/AN/AN/AN/A4.10N/AN/AN/AN/AN/A
Days of Inventory outstanding
N/AN/A1.56KN/AN/AN/AN/AN/AN/AN/AN/AN/A
Operating Cycle
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Days of Payables Outstanding
N/A20.78K5.53K9.20K9.67K4.66KN/AN/A515.93N/AN/A4.66K
Cash Conversion Cycle
N/AN/AN/AN/AN/AN/AN/AN/A-515.93N/AN/AN/A
Debt Ratios
Debt Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A0.14N/A
Debt Equity Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A0.17N/A
Long-term Debt to Capitalization
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A0.10N/A
Total Debt to Capitalization
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A0.11N/A
Interest Coverage Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Cash Flow to Debt Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A-3.33N/A
Company Equity Multiplier
1.021.031.071.071.221.151.741.081.171.641.171.17
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
N/AN/AN/AN/AN/AN/A-4.080.56-36.75-116.87-36.75N/A
Free Cash Flow / Operating Cash Flow Ratio
1.001.011.011.001.001.001.000.991.021.001.021.00
Cash Flow Coverage Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A-3.33N/A
Short Term Coverage Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A-103.43N/A
Dividend Payout Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A